NEWS

The Epilepsy Network (TEN) / News / FDA Approves Zonisamide Oral Suspension as Adjunctive Therapy For Epilepsy

Jul 20

FDA Approves Zonisamide Oral Suspension as Adjunctive Therapy For Epilepsy

The FDA has approved zonisamide oral suspension as an adjunctive therapy for patients with epilepsy…

Related

About The Author

The Epilepsy Network is a worldwide community of people with epilepsy, family and friends, uniting to talk about their experiences, learn information about epilepsy, ask questions and so much more! Don’t let epilepsy defeat you, let it inspire you!

Leave a reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

TWEETABLES

Copy any of the facts below to compose a tweet and raise awareness!

	65 million - Number of people worldwide with epilepsy
	1 in 26 people in the United States will develop epilepsy at some point in their lifetime
	6 out of 10 - Number of people with epilepsy in which the cause is unknown
	150,000 - Number of new cases of epilepsy in the United States each year

The Epilepsy Network (TEN) © 2024 | Website by 4FrontDesign